-+ 0.00%
-+ 0.00%
-+ 0.00%

Tsuruha Holdings (TSE:3391) Stock Price Trails Profit Growth As Margins Thin

Simply Wall St·10/09/2026 08:29:14
Listen to the news

Tsuruha Holdings shares come into this earnings recap under pressure, with the stock down roughly 9.5% over the past month even after a flat week. That cautious mood meets a pharmacy chain still reporting profit per share, with Q2 basic earnings at ¥36.99 and trailing twelve month basic EPS at ¥131.37.

The main focus for sentiment is on the balance sheet rather than the income statement. Recent shareholder dilution hangs over a business trading on an 18.2x P/E, while a discounted cash flow view suggests the current ¥2,114 price implies a steep valuation gap.

Is Tsuruha Holdings a genuine bargain at a 69.5% discount to a DCF estimate, or is that gap simply flagging hidden risks ahead? Compare the current share price against intrinsic value on our valuation analysis for Tsuruha Holdings.

Q2 2027 Earnings Summary

  • Revenue (Q2 2027 vs. Q2 2026): ¥638,628 million vs. ¥285,301 million (very large increase in reported quarterly sales)
  • Net Income (Q2 2027 vs. Q2 2026): ¥16,775 million vs. ¥9,253 million (very large increase in quarterly profit)
  • Basic EPS (Q2 2027 vs. Q2 2026): ¥36.99 vs. ¥37.98 (slight decline in earnings per share)
  • Trailing 12-Month Net Profit Margin (to Q2 2027 vs. prior year): 2.4% vs. 2.6% (mild compression in overall profitability)

Tired of scrolling through earnings tables and balance sheet line items for Tsuruha Holdings?

See the full picture of how the stock is valued at a glance in our visual company report for Tsuruha Holdings.

TSE:3391 Trailing 12-Month Earnings & Revenue History as at Oct 2026
TSE:3391 Trailing 12-Month Earnings & Revenue History as at Oct 2026

Tsuruha bullish story leans on resilient earnings

For anyone leaning optimistic on Tsuruha Holdings, the earnings line gives some support. Net income in Q2 2027 sits at ¥16,775 million, well ahead of last year’s ¥9,253 million, while revenue is also much higher. Profit per share is slightly softer, with basic EPS at ¥36.99 versus ¥37.98, which hints at dilution. Even so, the business still produces profit and a trailing net margin of 2.4%. For a defensive retailer tied to everyday healthcare spending, that mix of higher profit and ongoing earnings can fit a cautious long term view.

Margin pressure keeps the Tsuruha bear case alive

Bears pointing to pressure on profitability still have data on their side. Tsuruha Holdings shows a trailing 12 month net margin of 2.4%, down from 2.6%, which lines up with worries about competition and retail cost inflation. Basic EPS also edges lower year on year despite higher profit, reinforcing concerns around shareholder dilution. The share price has fallen about 9.5% over 30 days and roughly 6.3% over 90 days, which suggests investors remain wary about how much of that revenue scale actually converts into durable, per share earnings power.

After shareholder dilution and thinner margins, the key question is whether these are isolated issues or early signs of deeper structural problems. Review our risk analysis for Tsuruha Holdings which shows 1 important warning sign

Stay Ahead Of Your Next Move

If the mix of a wide DCF gap and recent share price pressure around Tsuruha Holdings has you watching for a better entry, register for free with Simply Wall St and add it to your Watchlist to track price against fair value in one place. Once you take a position, keep on top of what matters most to your holdings with the Portfolio Command Center, which filters routine noise and highlights material changes. For a longer term view, use the Community to see how other investors are thinking about risks, catalysts and sentiment shifts. That way you can surface potential problems or upside early and stay a step ahead of the market.

Curious About Alternatives Worth Exploring

Fresh ideas move first, and the strongest breakout stories often fly before the crowd catches on. Scan these focused lists while the data still matters and consider your options promptly.

  • Review our curated 28 dividend fortresses to spot income workhorses that aim to keep paying investors while prices swing, before yields potentially react to renewed buying momentum.
  • Scan the hand picked 33 best rare earth metal stocks to track future-facing miners tied to long term tech demand, while many of these opportunities remain under the radar for now.
  • Review our focused 43 power grid technology and infrastructure stocks to follow developments in tomorrow’s energy backbone, before the market fully reflects grid upgrade activity.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.